BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 22311829)

  • 1. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
    Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
    J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
    White RR; Kattan MW; Haney JC; Clary BM; Pappas TN; Tyler DS; Brennan MF
    Ann Surg Oncol; 2006 Nov; 13(11):1485-92. PubMed ID: 17013688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.
    Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL
    Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.
    Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
    Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
    JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma.
    Takahashi H; Ogawa H; Ohigashi H; Gotoh K; Yamada T; Ohue M; Miyashiro I; Noura S; Kishi K; Motoori M; Shingai T; Nakamura S; Nishiyama K; Yano M; Ishikawa O
    Surgery; 2011 Sep; 150(3):547-56. PubMed ID: 21621236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
    Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
    Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
    Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
    J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
    Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
    Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
    Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR
    Oncology; 2009; 76(6):413-9. PubMed ID: 19407474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the pancreatic head: a community teaching hospital's experience from 1982 to 1992.
    Falk J; Keidan R; Rigo PK; Dmuchowski C
    Am Surg; 1999 Jan; 65(1):15-8. PubMed ID: 9915524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer.
    Morganti AG; Falconi M; van Stiphout RG; Mattiucci GC; Alfieri S; Calvo FA; Dubois JB; Fastner G; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma NK; Ippolito E; Valentini V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):911-7. PubMed ID: 25220717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.